Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000314302 | SCV000330786 | pathogenic | not provided | 2025-01-14 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 35982159, 33057194, 35599849, 37643945, 39129698) |
Labcorp Genetics |
RCV000314302 | SCV001207274 | pathogenic | not provided | 2022-10-04 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with NEXMIF-related conditions. This sequence change creates a premature translational stop signal (p.Arg348*) in the NEXMIF gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NEXMIF are known to be pathogenic (PMID: 23615299). This variant is not present in population databases (gnomAD no frequency). ClinVar contains an entry for this variant (Variation ID: 280835). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic. |
Molecular Genetics Laboratory, |
RCV000767534 | SCV000898152 | pathogenic | X-linked intellectual disability, Cantagrel type | 2018-06-28 | no assertion criteria provided | clinical testing |